Nu Skin Enterprises stock faces a 17.1 percent revenue drop
Published on 10/04/2026 at 15:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Nu Skin Enterprises stock (ISIN US67018T1051) was last at USD 4.61 on the NYSE on October 2, 2026 at 4:00 p.m. ET, up 1.32 percent on the session. The company reported first half 2026 revenue of USD 640.7 million, down 14.6 percent from USD 750.6 million a year earlier, according to Direct Selling Magazine.
Revenue falls across the first half
The second quarter generated USD 320.1 million in revenue, compared with USD 386.1 million in Q2 2025. The 17.1 percent decline followed a 12.0 percent drop in the first quarter, showing that the contraction widened during the first half.
The half-year loss reached USD 248.0 million, compared with net income of USD 128.6 million in the prior-year period. The comparison includes a USD 176.2 million gain from the sale of Mavely in the earlier period, which makes the reported earnings gap particularly large.
Guidance sets a lower revenue base
Nu Skin expects 2026 revenue of USD 1.28 billion to USD 1.35 billion and adjusted earnings per share of USD 0.70 to USD 0.90, according to Direct Selling Magazine. The revenue range sits below the USD 1.49 billion reported for fiscal year 2025, while the adjusted earnings range points to a business reset after the weak first half.
MarketBeat lists a Sell consensus for Nu Skin based on 2 research reports, with an average rating score of 1.00, according to MarketBeat. Its outlook data also show projected earnings growth of 41.46 percent in the following year, a forecast that depends on the recovery implied by management guidance.
Stock remains near its yearly low
NUS had a USD 4.45 52-week low and a USD 11.67 52-week high in the finance quote on October 2, 2026. Its USD 4.61 price therefore stood USD 0.16 above the yearly low, while the market capitalization was USD 223.8 million and trading volume reached 376,367 shares.
The valuation picture is tied to execution rather than headline growth: Q2 revenue was USD 320.1 million, operating margin was negative 19 percent, and operating cash flow was USD 10.6 million. For investors, the key checkpoint is whether the adjusted EPS range of USD 0.70 to USD 0.90 can be supported while revenue remains below the fiscal year 2025 level.
NUS price and market value
Nu Skin Enterprises stock was last at USD 4.61 on the NYSE on October 2, 2026 at 4:00 p.m. ET. The company had a market capitalization of USD 223.8 million on that date.
Nu Skin Enterprises stock facts
- Company: Nu Skin Enterprises, Inc.
- ISIN: US67018T1051
- WKN: 903911
- Ticker: NUS
- Trading venue: NYSE
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 4.61
- Market capitalization: USD 223.8 million (as of October 2, 2026)
- 52-week range: USD 4.45-11.67 (as of October 2, 2026)
- Sector / Industry: Consumer Defensive / Household and Personal Products
